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The serum angiotensin-converting enzyme ( A C E ) plays an important 
role in regulation of circulat ing vasoactive peptides. A C E realizes the interre-
lation between k in in and renin-angiotensin system ( R A S ) by means of con-
verting angiotensin — I into angiotensin — I I and of simultaneous inact ivat ion 
of the hypotensive bradykin in (1,4) . 
A number of authors confirmed its importance for the diagnostics and treat-
ment of sarcoidosis (11). A C E diagnostic significance in various kinds of pulmo-
nary , sk in , heart, and liver diseases was also discussed (7, 8, 10, 13). Recently, 
treatment of severe hypertension which is hard to be we l l in hand was directed 
towards A C E - i n h i b i t i n g drugs (1) . A C E intrarenal secretion, its high tubu-
lar epitheloid cells ' concentration, its impossibil i ty to pass through the intact 
glomerule as wel l as the attempt to find a manner of treating severe, even dia-
lysis-resistent hypertension asks a question of its diagnostical importance 
in chronic renal failure ( C R F ) patients (12). H a v i n g in mind the possibilities 
for altering the lung epitheloid cells during hemodialysis ( H D ) and the related 
disturbances of k in in , f ibrinolytic , complement, and renin-angiotensin sys-
tems (2, 3, 4, 5, 9, 12), we had the a im to study A C E changes in C R F patients on 
chronic H D . 
Material and methods 
A C E level was studied in a total of 84 individuals divided into 3 groups: \ s t — 
24 C R F patients (19 males and 5 females) aged between 20 and 54 years on 
maintenance H D for 3 t i l l 94 months long twice-thrice weekly wi th total du-
ration of 12—15 hours by using the dialysator capi l la ry type " C O R D I S " ( U S A ) . 
Blood pressure 26,6—15,3/15,93—7,98 k P a , at the average 19,42 (11,17 k P a ; 
I I n d — 6 C R F patients (3 males and 3 females) aged between 30 and 56 years on 
conservative therapy; I I I r d — 54 c l in ica l ly healthy blood donors (30 males and 24 
females) aged between 20 and 50 years. 
The serum A C E was determined spectrophotometrically according to Cushmas 
et Cheung's method (6) by using as substrate hippuri l , h i s t idy l , leucine — S E R V A 
( G F R ) . I t was estimated in nmol/ml/min. Blood samples were taken in the morn-
ing before meal at 0 °C. I t was done in H D patients before and after H D by using 
venous puncture of the arteriovenous fistula. H D patients' renin ac t iv i ty was 
determined in ng/ml/h by means of a radioimmunological method wi th test pack-
age from the firm "Rotop" ( G D R ) . 
The results obtained were processed s ta t is t ica l ly according to the method 
of var ia t ion analysis and presented on tables. 
Angiotensin-converting enzyme in. 
Results and discussion 
A C E level didn't change s tat is t ical ly significantly in C R F patients both on 
H D (20,16=7,16) and without H D (18,37=8,55) as compared wi th that of the 
controls (19,57=6,88) (p>0,05) (see table 1). The dialysis procedure didn't cause 
T a b l e 1 
ACE in CRF patients on HD and concervative treatment in nmol/ml/min 




before HD after HD 
x 19,57 18,73 20,16 23,26 
S 6,88 8,55 7,16 12,05 
Sx 0,93 3,82 1,46 2,40 
any stat is t ical ly reliable changes of A C E values (from 20,16=7,16 before H D 
t i l l 23,28=12,05 after H D ) (p>0,05) (table 1). Th i s tendency towards A C E in-
crease immediately after H D (table 1) is clarified after separation of certain H D 
patients wi th A C E values exceeding x + 2 S (table 2 and 3) at the end of H D . F r o m 
T a b l e 2 
ACE in a group of 6 males with CRF on chronic HD according to x and 2S rates 










this point of v iew it is to be noted that these patients show significant A C E chan-
ges (p<0,05) at the end of H D and even before it as compared wi th the controls 
and C R F patients. 
A comparison is made wi th a collected control group (both males and fema-
les) as we l l as wi th a control group of 30 healthy blood donors (males). There is 
no relation between A C E changes, on the one hand, and age, blood pressure, and 
H D duration, on the other. The assessment of renin did not reveal any significant 
changes at the end of H D both in the collected group of dialysed patients (2,52 = 
=±=0,36 before H D ; 2,18=0,48 after H D ) (p>0,05) and in the separated one (wi th 
higher A C E level (3 ,84=1,30 before H D and 1,98=0,55 after H D ) (p>0 ,05 ) . 
A C E level in H D patients was studied in a generalized group of C R F patients 
(on H D and conservative treatment) by R . Patel et a l . (12) who could not estab-
l i sh any significant A C E changes in these patients as compared wi th those of the 
controls. However, they found out a s ta t is t ical ly reliable A C E difference in H D 
70 P. Chankova, D. Nenov, T. Yankova, T. Ruseva 
T a b l e 3 
Age, blood pressure and HD duration differences in 6 males with ACE levels 










N . I . 40 21,71 13,30 7 glomerulo­
nephritis 
P . D. 50 21,23 13,30 22 pyelonephritis 
Y . U . 37 17,29 15,96 19 polycystic 
disease 
G . B . 51 17,29 17,29 94 gout neph­
ritis 
E . P . 37 17,29 17,29 75 glomerulo­
I . G . 
nephritis 
39 21,28 18,02 14 
patients correlating wi th H D duration. Our results do not demonstrate such a 
correlation (table 3). I n contrast to R . Patel ' s et a l . data we establish a distinct 
A C E increase in 25 per cent of the patients at the end of H D (p<0 ,05 — table 2) 
and after repeated H D as compared wi th that of the healthy controls. 
According to some recent results (3, 5), lung endothelial cells are damaged 
during H D procedure. Hav ing in mind the enzyme localization in them (7, 8) 
A C E increase after H D could be due to these changes in 25 per cent of the patients. 
The reaction of some patients as proved by R . Patel et a l . can ' t exclude patients' 
indiv idual response against HD-induced hemostatic disturbances and the diffe­
rent degree of complement act ivat ion followed by leukocyte microembolism (3) . 
HD-induced disbalance in R A S , k in in -ka l l ik re in , and f ibr inolyt ic systems con­
firms our previous investigations (2). HD-induced A C E increase can be directly 
related to the increase of the total proteolytic ac t iv i ty following the decrease of 
some inhibitors of these systems (2) . Our results support the lack of correlation 
between renin and blood pressure in H D patients reported by D . Koev et a l . (4) 
on the one hand, and, between A C E , blood pressure, hematocrit, and age accord­
ing to R . Patel et a l . (12), on the other. 
I t is obvious that the problem is very complicated and requires further inves­
tigations. 
We can conclude that A C E changes in C R F patients on H D and conserva­
tive treatment are insignificant in comparison wi th these of healthy controls 
(p>0 ,05) . I n 25 per cent of H D patients there is, however, a s ta t i s t ica l ly re l iable 
A C E increase after H D (p<0 ,05) . There is not any correlation between A C E 
changes, H D duration, patients' age, blood pressure and renin. 
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Р Е З Ю М Е 
Уровень ангиотензин-конвертинг энзима исследовался спектрофотометрическим мето­
дом Cushmas u Cheung. 
Проведено исследование 84 больных, которые были распределены в три подгруппы: 
I группа — больных хронической почечной недостаточностью, лечившихся гемодиализом; 
I I группа — больных хронической почечной недостаточностью, лечившихся консервативно; 
I I I группа (контрольная) — клинически здоровых лиц. Не было установлено статистически 
значимых различий уровня ангиотензинконвертинг энзима у больных хронической почеч­
ной недостатачностью на гемодиализе и у тех, которые лечились консервативно, по сравне­
нию с контрольной группой клинически здоровых лиц. Статистически значимое повышение 
количества ангиотензин-конвертинг энзима после проведенного гемодиализа наблюдалось 
у 25 % больных, лечившихся этим методом. Полученные результаты не дают оснований уста­
новить регулярную связь между изменениями ангиотензин-конвертинг энзима, продолжи­
тельностью хронического диализа, возрастом больных, уровнем кровяного давления и ко ­
личеством ренина. 
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